Experiment 69632
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Boswellia carteri (BURSERACEAE) |
| Citation | BADRIA,FA: EL-FARAHATY,T: SHABANA,AA: HAWAS,SA: EL-BATOTY,MF:. (2002). BOSWELLIA-CURCUMIN PREPARATION FOR TREATING KNEE OSTEOARTHRITIS.. 2002() |
| Amount utilized | |
| Compound isolated | |
| Disease | AND INCREASED WALKING DISTANCE. THE FREQUENCY OF SWELLING IN THE KNEE JOINT WAS DECREASED. RADIOLOGICALLY THERE WAS NO CHANGE. THE OBSERVED DIFFERENCES BETWEEN DRUG TREATMENT AND PLACEBO BEING STATISTICALLY SIGNIFICANT, ARE CLINICALLY FOR 8 WKS. AFTER THE FIRST INTERVENTION, WASHOUT WAS GIVEN AND THEN THE GROUPS WERE CROSSED OVER TO RECEIVE THE OPPOSITE INTERVENTION FOR 8 WKS. ALL THE PATIENTS RECEIVING DRUG TREATMENT REPORTED DECREASE IN KNEE PAIN, INCREASED KNEE FLEXION A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED CROSSOVER STUDY WAS CONDUCTED TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF BOSWELLIA SERRATA EXTRACT(BSE) IN 30 PATIENTS OF OSTEOARTHRITIS OF KNEE, 15 EACH RECEIVING ACTIVE DRUG OR PLACEBO RELEVANT. BSE WAS WELL TOLERATED BY THE SUBJECTS EXCEPT FOR MINOR GASTROINTESTINAL ADRS. BSE IS RECOMMENDED IN THE PATIENTS OF OSTEOARTHRITIS OF THE KNEE WITH POSSIBLE THERAPEUTIC USE IN OTHER ARTHRITIS. |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |
| Gender | GIVEN TO BOTH SEXES |